{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:20:22Z","timestamp":1788848422402,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.vaccine.2016.08.055","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T23:13:31Z","timestamp":1473462811000},"page":"5449-5456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical testing of an inactivated influenza A\/H5N1 vaccine candidate in a double-blinded, placebo-controlled, randomized trial in healthy adults in Vietnam"],"prefix":"10.1016","volume":"34","author":[{"given":"Trong Lan","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh Thang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Huong","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuyet Nga","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huu Thai","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahnuma","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2016.08.055_b0005","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3201\/eid1406.070839","article-title":"Major issues and challenges of influenza pandemic preparedness in developing countries","volume":"14","author":"Oshitani","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.055_b0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/vr.157.6.159","article-title":"Origin and evolution of highly pathogenic H5N1 avian influenza in Asia","volume":"157","author":"Sims","year":"2005","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2016.08.055_b0015","series-title":"WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics","author":"World Health Organization","year":"2005"},{"key":"10.1016\/j.vaccine.2016.08.055_b0020","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.32.19941-en","article-title":"Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010","volume":"16","author":"Fiebig","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.08.055_b0025","series-title":"Cumulative number of confirmed human cases for avian influenza A (H5N1) reported to WHO, 2003\u20132016","author":"World Health Organization","year":"2016"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.08.055_b0030","doi-asserted-by":"crossref","first-page":"A34","DOI":"10.1016\/j.vaccine.2011.04.118","article-title":"Development of pandemic influenza vaccine production capacity in Viet Nam","volume":"29","author":"Hoa","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.055_b0035","series-title":"Post-approval safety data management: definitions and standards for expedited reporting","author":"IHC Expert Working Group","year":"2003"},{"key":"10.1016\/j.vaccine.2016.08.055_b0040","unstructured":"Webster RG, Krauss S. World Health Organization. Global Influenza Program. WHO manual on animal influenza diagnosis and surveillance; 2002 Available from: <http:\/\/www.wpro.who.int\/emerging_diseases\/documents\/docs\/manualonanimalaidiagnosisandsurveillance.pdf>."},{"key":"10.1016\/j.vaccine.2016.08.055_b0045","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.055_b0050","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1016\/j.vaccine.2009.06.057","article-title":"Safety and immunogenicity of a subvirion inactivated influenza A\/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults","volume":"27","author":"Brady","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.055_b0055","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(00)00395-9","article-title":"Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans","volume":"19","author":"Treanor","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.055_b0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0092-1157(79)80044-X","article-title":"Clinical studies of monovalent inactivated whole virus and subunit A\/USSR\/77 (H1N1) vaccine: serological responses and clinical reactions","volume":"7","author":"Nicholson","year":"1979","journal-title":"J Biol Stand"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.08.055_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virusres.2004.02.029","article-title":"Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use","volume":"103","author":"Hehme","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.08.055_b0070","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.vaccine.2008.05.077","article-title":"Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults","volume":"26","author":"Nolan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.055_b0075","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"Bresson","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.055_b0080","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/infdis\/jiq093","article-title":"Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant","volume":"203","author":"Belshe","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.055_b0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1348-0421.2009.00191.x","article-title":"Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection","volume":"54","author":"Ikeno","year":"2010","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2016.08.055_b0090","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/CVI.00096-13","article-title":"An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A\/Chicken\/Astana\/6\/05) influenza vaccine is safe and immunogenic in a single dose in humans","volume":"20","author":"Sansyzbay","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.08.055_b0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1750-2659.2008.00067.x","article-title":"Safety and immunogenicity of Sinovac\u2019s prototype pandemic influenza H5N1 vaccines: a review on clinical trials","volume":"2","author":"Qiu","year":"2008","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2016.08.055_b0100","doi-asserted-by":"crossref","first-page":"e4028","DOI":"10.1371\/journal.pone.0004028","article-title":"Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A\/H5N1 vaccine in children","volume":"3","author":"Chotpitayasunondh","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.055_b0105","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1086\/652701","article-title":"Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1\/2 trial in adults","volume":"201","author":"Langley","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.055_b0110","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.055_b0115","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults","volume":"197","author":"Bernstein","year":"2008","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:28:56Z","timestamp":1657247336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":23,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0264410X16307423"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical testing of an inactivated influenza A\/H5N1 vaccine candidate in a double-blinded, placebo-controlled, randomized trial in healthy adults in Vietnam","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}